266 related articles for article (PubMed ID: 33724653)
1. Histological and mutational profile of diffuse gastric cancer: current knowledge and future challenges.
Garcia-Pelaez J; Barbosa-Matos R; Gullo I; Carneiro F; Oliveira C
Mol Oncol; 2021 Nov; 15(11):2841-2867. PubMed ID: 33724653
[TBL] [Abstract][Full Text] [Related]
2. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological features and cancer transcriptomic profiling of poorly cohesive gastric carcinoma subtypes.
Yen HH; Chen PY; Huang RY; Jeng JM; Lai IR
J Pathol Clin Res; 2024 Jul; 10(4):e12387. PubMed ID: 38860888
[TBL] [Abstract][Full Text] [Related]
4. Wnt Signaling Shapes the Histologic Variation in Diffuse Gastric Cancer.
Togasaki K; Sugimoto S; Ohta Y; Nanki K; Matano M; Takahashi S; Fujii M; Kanai T; Sato T
Gastroenterology; 2021 Feb; 160(3):823-830. PubMed ID: 33217450
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
6. Destabilized adhesion in the gastric proliferative zone and c-Src kinase activation mark the development of early diffuse gastric cancer.
Humar B; Fukuzawa R; Blair V; Dunbier A; More H; Charlton A; Yang HK; Kim WH; Reeve AE; Martin I; Guilford P
Cancer Res; 2007 Mar; 67(6):2480-9. PubMed ID: 17363565
[TBL] [Abstract][Full Text] [Related]
7. Histopathologic Analysis of Signet-ring Cell Carcinoma In Situ in Patients With Hereditary Diffuse Gastric Cancer.
Tsugeno Y; Nakano K; Nakajima T; Namikawa K; Takamatsu M; Yamamoto N; Fujisaki J; Nunobe S; Kitagawa M; Takeuchi K; Kawachi H
Am J Surg Pathol; 2020 Sep; 44(9):1204-1212. PubMed ID: 32520759
[TBL] [Abstract][Full Text] [Related]
8. Gastric Adenocarcinomas and Signet-Ring Cell Carcinoma: Unraveling Gastric Cancer Complexity through Microbiome Analysis-Deepening Heterogeneity for a Personalized Therapy.
Ravegnini G; Fosso B; Saverio VD; Sammarini G; Zanotti F; Rossi G; Ricci M; D'Amico F; Valori G; Ioli A; Turroni S; Brigidi P; Hrelia P; Angelini S
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419357
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological characteristics and prognosis of poorly cohesive cell subtype of gastric cancer.
Nakamura K; Eto K; Iwagami S; Ogawa K; Sawayama H; Ishimoto T; Iwatsuki M; Baba Y; Miyamoto Y; Yoshida N; Baba H
Int J Clin Oncol; 2022 Mar; 27(3):512-519. PubMed ID: 35084597
[TBL] [Abstract][Full Text] [Related]
10. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
[TBL] [Abstract][Full Text] [Related]
11. Molecular profile of poorly cohesive gastric carcinoma with special reference to survival.
Koseki Y; Hatakeyama K; Terashima M; Nagashima T; Urakami K; Ohshima K; Aizawa D; Sugino T; Furukawa K; Fujiya K; Tanizawa Y; Bando E; Okamura Y; Akiyama Y; Yamaguchi K
Gastric Cancer; 2023 Jul; 26(4):553-564. PubMed ID: 37036539
[TBL] [Abstract][Full Text] [Related]
12. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer.
Shi W; Wang Y; Xu C; Li Y; Ge S; Bai B; Zhang K; Wang Y; Zheng N; Wang J; Wang S; Ji G; Li J; Nie Y; Liang W; Wu X; Cui J; Wang Y; Chen L; Zhao Q; Shen L; He F; Qin J; Ding C
Nat Commun; 2023 Feb; 14(1):835. PubMed ID: 36788224
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of novel gastric signet-ring cell and non signet-ring cell poorly differentiated adenocarcinoma cell lines with low and high malignant potential.
Murakami H; Nakanishi H; Tanaka H; Ito S; Misawa K; Ito Y; Ikehara Y; Kondo E; Kodera Y
Gastric Cancer; 2013 Jan; 16(1):74-83. PubMed ID: 22450770
[TBL] [Abstract][Full Text] [Related]
14. Potential of Helicobacter pylori-uninfected signet ring cell carcinoma to invade the submucosal layer.
Yorita N; Ito M; Boda T; Kotachi T; Nagasaki N; Abuduwaili M; Hata K; Hiyama Y; Oka S; Yoshihara M; Kitadai Y; Tanaka S; Chayama K
J Gastroenterol Hepatol; 2019 Nov; 34(11):1955-1962. PubMed ID: 31062875
[TBL] [Abstract][Full Text] [Related]
15. Hereditary diffuse gastric cancer: translation of CDH1 germline mutations into clinical practice.
Guilford P; Humar B; Blair V
Gastric Cancer; 2010 Mar; 13(1):1-10. PubMed ID: 20373070
[TBL] [Abstract][Full Text] [Related]
16. Consensus on the pathological definition and classification of poorly cohesive gastric carcinoma.
Mariette C; Carneiro F; Grabsch HI; van der Post RS; Allum W; de Manzoni G;
Gastric Cancer; 2019 Jan; 22(1):1-9. PubMed ID: 30167905
[TBL] [Abstract][Full Text] [Related]
17. Comparison between signet-ring cell carcinoma and non-signet-ring cell carcinoma of the stomach: clinicopathological parameters, epidemiological data, outcome, and prognosis-a cohort study of 123 patients from a non-endemic country.
Zaafouri H; Jouini R; Khedhiri N; Khanchel F; Cherif M; Mesbahi M; Daghmouri A; Mahmoudi W; Akremi S; Sabbah M; Benzarti Y; Hadded D; Gargouri D; Bader MB; Maamer AB
World J Surg Oncol; 2022 Jul; 20(1):238. PubMed ID: 35858903
[TBL] [Abstract][Full Text] [Related]
18. Hereditary gastric cancer.
Carneiro F
Pathologe; 2012 Nov; 33 Suppl 2():231-4. PubMed ID: 23052347
[TBL] [Abstract][Full Text] [Related]
19. Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model.
Yamaguchi K; Yoshihiro T; Ariyama H; Ito M; Nakano M; Semba Y; Nogami J; Tsuchihashi K; Yamauchi T; Ueno S; Isobe T; Shindo K; Moriyama T; Ohuchida K; Nakamura M; Nagao Y; Ikeda T; Hashizume M; Konomi H; Torisu T; Kitazono T; Kanayama T; Tomita H; Oda Y; Kusaba H; Maeda T; Akashi K; Baba E
Gastric Cancer; 2022 Sep; 25(5):862-878. PubMed ID: 35661943
[TBL] [Abstract][Full Text] [Related]
20. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge.
Pernot S; Voron T; Perkins G; Lagorce-Pages C; Berger A; Taieb J
World J Gastroenterol; 2015 Oct; 21(40):11428-38. PubMed ID: 26523107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]